Wed, Aug 5, 2015
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Lyxor Global Hedge Fund Index up 2.3% in December (+5.8% in 2010)

Monday, January 17, 2011
Opalesque Industry Update - The Lyxor Global Hedge Fund Index, an investable index based on Lyxor’s hedge funds platform which tracks the overall hedge fund universe, was up 5.8% in 2010. The index gained 2.3% in December.

Alternative investments had persistent themes from which to benefit in December 2010. Equity markets finished 2010 on a strong note, with the S&P 500 posting a total return of 6.7% in December. Commodity markets generally followed the same trend. The CRB Commodity Index gained just over 10% on the month, with both the energy and non-energy components exhibiting significant performances. Metals, both precious and industrial, saw similar gains.

The strong December trend in risk assets provided clear benefits for CTAs. Long equities and commodities position, short bond positions made the Lyxor Long-Term CTA Index gained 2.5% over the month, leading to a 10.2% gain over the calendar year. Short-Term CTAs finally found traction in December, with the Lyxor Index up 0.8% (although it fell 0.1% over the whole of 2010).

Global Macro managers were able to harvest gains from opportunity-rich markets; the Lyxor Global Macro Index surged 4.7%. Commodity-oriented managers benefited from continued supply constraints and Emerging Market demand. Macro managers who are bullish were buoyed by risk asset gains, including double digit gains in silver, palladium, and copper. Spread tightening helped managers in the Lyxor L/S Credit Index gain 1.0% for a 10.3% gain on the year. Some of the same fundamental drivers benefited convertible traders, with the Lyxor Convertible Arbitrage Index up 0.7% for December and 4.9% on the year. Fixed Income Arbitrage provided little excitement, as the index declined -0.4%. Despite this year-end lull, the net result for the Lyxor Fixed Income Arbitrage Index was 9.5% for 2010.

Event Driven managers performed well. The Lyxor Distressed Index gained 0.6%, capping a +5.3% year. The Lyxor Merger Arbitrage Index rebounded from its November decline and posted a +1.3% performance. The proportion of deals with negative spreads eased as we moved into year-end, signalling slightly less aggressiveness in pricing for the new year. Performance for the year was a solid 5.8%. Special Situations managers strongly benefited from equity and credit market performance, gaining 4.3% for the month (10.3% on the year). L/S Equity managers tended to increase their net and gross exposures during the fourth quarter of the year, and this generally paid off in December. Both the Lyxor L/S Equity Variable Bias Index and Long Bias Index gained 2.7%. Long Bias managers were much more exposed throughout the year to the double digit gains in broad equity markets (and were early in moving to higher net exposures), leading to +6.2% gains for the year versus +2.3% for the Variable Bias Index.

Market-neutral managers benefited from greatly diminished correlations among stocks, meaning that good stock selection was finally rewarded after months of the “Risk On/Risk Off” trade dominating. The L/S Equity Market Neutral Index gained 0.9% to eke out 1.4% on the year. Statistical Arbitrage managers continued to struggle, however. The Lyxor L/S Statistical Arbitrage Index was up a modest 0.2%, bringing the year-to-date number to -1.2%.

Corporate website: www.lyxor.com

- FG

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Activist News - Celgene says patent-fighting hedge fund manager wants to short its shares[more]

    From Reuters.com: Celgene Corp, one of the world's largest biotechnology companies, has accused U.S. hedge fund manager Kyle Bass of attempting to profit from his attempts to wipe out several major drug patents through his Coalition for Affordable Drugs. The company asked the U.S. Patent and T

  2. Einhorn's Greenlight Capital hedge fund slumps 6.1 percent in July[more]

    From Reuters/Thefiscaltimes.com: Hedge fund mogul David Einhorn's Greenlight Capital slumped 6.1 percent in July and is now down 9 percent for the year after gold, one of the fund's top holdings, tumbled to five-year lows last week. Greenlight notified clients of its returns late on Friday, ac

  3. Performance - Some hedge fund small-cap energy stocks have been free falling, Dan Loeb's simple strategy destroys the market, Baupost lost 1.4% last quarter as energy bargains proved elusive[more]

    Some hedge fund small-cap energy stocks have been free falling From Marketrealist.com: According to a July 28, 2015, Bloomberg article, there was a 34% fall in small-cap energy stocks over the past three months. These shares are tracked by the Russell 2000 Energy Index. Small-cap energy

  4. Legal - Hedge funds hit Rothstein Kass with $75m malpractice suit, JPMorgan questioned on private bank’s hedge fund disclosures, Kijani fund, seized by regulators in Cayman Islands, spotlights risks in lightly regulated market[more]

    Hedge funds hit Rothstein Kass with $75m malpractice suit From Law360.com: Two investment funds have sued Rothstein Kass & Co. PC for at least $75 million, claiming the New Jersey auditing firm committed accounting malpractice by failing to properly scrutinize overblown valuations of the

  5. Assets - Hedge funds are getting smoked by the commodities slump, Global ETF assets could more than double by 2020[more]

    Hedge funds are getting smoked by the commodities slump From Businessinsider.in: The collapse in commodity prices has burnt another hedge fund. Vermillion, a commodity hedge fund backed by Carlyle Group, has seen its flagship fund's assets fall from nearly $2 billion to less $50 million,

 

banner